Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.
Doron Therapeutics has raised $11.0M in total funding. The most recent round was Series A. The last funding was announced in November 2024.
Doron Therapeutics's investors include SPRIM Global Investments.
Doron Therapeutics is headquartered in Chapel Hill, United States.
Doron Therapeutics is a clinical-stage biotechnology company that has developed intra-articular biologic drug derived from placental tissue.
Doron Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Doron Therapeutics — Funding & Investors." VCBacked, November 25, 2024, https://www.vcbacked.co/company/doron-therapeutics. Accessed August 1, 2026.
VCBacked. (2024). Doron Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/doron-therapeutics
{{cite web |title=Doron Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/doron-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated